| D007223 |
Infant |
A child between 1 and 23 months of age. |
Infants |
|
| D007557 |
Israel |
A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. The capital is Jerusalem. |
|
|
| D004872 |
Ergocalciferols |
Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. |
Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000747 |
Anemia, Hypochromic |
Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393) |
Chlorosis,Anemias, Hypochromic,Chloroses,Hypochromic Anemia,Hypochromic Anemias |
|
| D014808 |
Vitamin D Deficiency |
A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p1406) |
Deficiency, Vitamin D,Deficiencies, Vitamin D,Vitamin D Deficiencies |
|
| D015652 |
25-Hydroxyvitamin D 2 |
9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3. |
25-Hydroxyergocalciferol,25-Hydroxycalciferol,25-Hydroxyvitamin D2,9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol,Ercalcidiol,25 Hydroxycalciferol,25 Hydroxyergocalciferol,25 Hydroxyvitamin D 2,25 Hydroxyvitamin D2 |
|
| D015995 |
Prevalence |
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. |
Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences |
|